https://www.selleckchem.com/pr....oducts/nazartinib-eg
To evaluate the predictive validity of multimodal clinical assessment outcomes and quantitative measures of in- and off-laboratory mobility for fall-risk estimation in patients with different forms of neurological gait disorders. The occurrence, severity, and consequences of falls were prospectively assessed for 6months in 333 patients with early stage gait disorders due to vestibular, cerebellar, hypokinetic, vascular, functional, or other neurological diseases and 63 healthy controls. At inclusion, participants compl
Curtir
Comentario
Compartilhar
